Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Alessandra Bosch: Swiss Medical Weekly Publishes National Guidance on Desmopressin for Bleeding Disorders
Oct 22, 2026, 06:17

Alessandra Bosch: Swiss Medical Weekly Publishes National Guidance on Desmopressin for Bleeding Disorders

Alessandra Bosch, Clinician Scientist at University of Zurich, shared a post on LinkedIn abouta recent article she and her colleagues co-authored, published in Swiss Medical Weekly, adding:

“The Swiss guidance on desmopressin (DDAVP) has now been published in Swiss Medical Weekly!

The paper provides practical guidance on the use of desmopressin in non-severe Haemophilia A, von Willebrand Disease, mild Platelet Function Disorders and BDUC bleeding disorders of unknown cause.

Key practical points:

  • DDAVP can be used to treat or prevent bleeding.
  • BUT: The response cannot be predicted from baseline FVIII and VWF levels.
  • A desmopressin trial is recommended to verify tolerability and identify responders.
  • Guidance covers dosing, fluid restriction, monitoring and interpretation, including paediatric specifics.

Sincere thanks to Eugenia Biguzzi who led this project, to all co-authors Alessandro Casini, Johanna Kremer Hovinga, Lorenzo ALBERIO, Pierre Fontana, Anne Angelillo-Scherrer, Bernhard Gerber, and to the members of the WPH-SSH and the SHN for a truly collaborative national effort.”

Title: Desmopressin (DDAVP): indications and practicalities

Authors: Eugenia Biguzzi, Alessandro Casini, Alessandra Bosch, Johanna A. Kremer Hovinga, Lorenzo Alberio, Pierre Fontana, Anne Angelillo-Scherrer, Bernhard Gerber, Working Party of Haemostasis of the Swiss Society of Haematology, Swiss Haemophilia Network

Alessandra Bosch

More posts featuring Alessandra Bosch on Hemostasis Today.